BECTON, DICKINSON AND COMPANY Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
BECTON, DICKINSON AND COMPANY (BDX) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $77.66 per share for the 12-month period ending 2017-09-30, per its 10-K filed 2017-11-22.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2017-11-22
- BECTON, DICKINSON AND COMPANY share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2017 was $77.66, a 2.03% decline from fiscal 2016.
- BECTON, DICKINSON AND COMPANY share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2016 was $79.27, a 5.29% decline from fiscal 2015.
- BECTON, DICKINSON AND COMPANY share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2015 was $83.70.
- BECTON, DICKINSON AND COMPANY share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2013 was $42.65, a 18.01% increase from fiscal 2012.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month |
|---|---|
| 2017-09-30 | $77.66 10-K · filed 2017-11-22 |
| 2016-09-30 | $79.27 10-K · filed 2016-11-23 |
| 2015-09-30 | $83.70 10-K · filed 2015-11-25 |
| 2014-09-30 | $49.43 8-K · filed 2015-03-13 |
| 2013-09-30 | $42.65 10-K · filed 2013-11-27 |
| 2012-09-30 | $36.14 10-K · filed 2012-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |